Insulin receptor-regulating antibodies (XOMA)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin receptor-regulating antibodies (XOMA)
Drug Alias NameXMetD antibody fragment (Fab)XMet programXOMA-129XMetDXMetA +[7] 
ClassificationBiologics
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsHypoglycemiaDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXoma Corp
Active IndicationsN/A
Inactive IndicationsHypoglycemiaDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A